Daijiworld Media Network - Panaji (RS)

Panaji, Jul 4: Mumbai-based Indoco Remedies Ltd has announced that its solid dosage facility at Goa, Plant I has received approval from Brazilian food and drug agency, Anvisa, marking the beginning of company's foray into one of the largest pharmaceutical market in the world.

"This approval paves way for contract manufacturing opportunities for Indoco in Brazil,'' stated Aditi Kare Panandikar, director business development, Indoco Remedies.

Indoco Remedies is a fast growing Indian Company involved in Research and Development, Manufacturing, Marketing and Distribution of Pharmaceutical products and services in the Domestic and International Market, she said.

"As a part of companies growth strategy and to move up the value chain, Indoco Remedies intends to enter newer, semi-regulated and regulated markets worldwide after getting approvals from the respective regulatory authorities," Panandikar said in a press release.

In addition, Indoco Remedies is working towards obtaining MCC approvals, for their Solid dosage as well as sterile plants, says the release.

"Out of Company's two manufacturing facilities at Goa , plant I is approved by MHRA-UK, for Tablets, Cream and Capsules and by Darmstadt Germany for Solid Dosages. Plant II is a state-of-the-art sterile facility for Ophthalmics and Injectables approved by USFDA,'' release adds.